V
主页
Na+-D-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption a
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
Sodium–glucose cotransporter 2 inhibition suppresses HIF-1α-mediated metabolic s
Activation of intestinal hypoxia-inducible factor 2α during obesity contributes
Intestinal Bacterial Translocation Contributes to DKD
LN guideline
Protocadherin 7-Associated Membranous Nephropathy
NCAM1 is novel autoantigen in MLN
N-glycosylation and igD multiple myeloma
intestinal microbiota control acute kidney injury severity by immune modulation
F . nucleatum targets lncRNA ENO1- IT1 to promote glycolysis and oncogenesis in
Fusobacterium nucleatum--rheumatoid arthritis
Emerging Modes of Treatment of IgA Nephropathy
Evidence for immune etiology of MCD
沙库巴曲缬沙坦降低射血分数保留型心衰患者收缩压
Rituximab in IMN
KP6通过靶向Wnt-βcatenin信号改善糖尿病肾病
Expansion of Escherichia-Shigella in Gut is Associate with IgAN
Urinary metabolite profiling and risk of progression of DN
Annexin A1 alleviates kidney injury by promoting the resolution of inflammation
Apixaban versus warfarin in patients with atrial fibrillation and advanced CKD
肾功能正常的高钾血症
urinary exosomal hsa-circ-0001250
DN中肌酐排泄率与死亡率的关系
clinical features and survival outcomes in IgD myeloma
Endogenous adenine mediates kidney injury in diabetic models and predicts DKD in
Gut microbiota profile and selected plasma metabolites in type 1 diabetes withou
磷酸盐肾病
Crystalglobulin-Induced Nephropathy
the relationship between BP and risk of renal cell carcinoma
Complement C5a induces renal injury in diabetic kidney disease
The N-termianl region of THSD7A is predominant target in THSD7A-associated MN
Interaction between drugs and the gut microbiome
BMI and risk of obesity-related complex multimorbidity
卡格列净与2型糖尿病肾病的肾脏预后
kidney injury molecule-1
Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance
Canagliflozin reduces inflammation and fibrosis biomarkers
autoantibodies targeting nephrin in MCD supports a novel autoimmune etiology
2种免疫抑制剂对IgA的影响
ANCA-associated vasculitis, Kdigo Guideline
Effects of finerenone in people with chronic kidney disease(0416.165754)